Table 1.
Included papers and studies, by category
| No. of papers/studies | |
|---|---|
| Measurement property | |
| Construct validity | 73/1363 |
| Test-retest reliability | 25/61 |
| Responsiveness | 16/80 |
| PBM | |
| EQ-5D-3L | 46/498 |
| EQ-5D-5L | 28/311 |
| EQ-VAS | 37/405 |
| SF-6D | 20/197 |
| HUI2 | 2/16 |
| HUI3 | 6/55 |
| QWB | 2/22 |
| Country/district | |
| China | 19/376 |
| Hong Kong | 10/177 |
| Japan | 5/38 |
| Malaysia | 4/21 |
| Singapore | 19/374 |
| South Korea | 7/159 |
| Taiwan | 6/184 |
| Thailand | 6/146 |
| Vietnam | 1/12 |
| Indonesia | 2/17 |
| Disease groups | |
| Cancer | 10/225 |
| Developmental disease | 1/14 |
| Diabetes | 5/56 |
| Eye disease | 3/32 |
| Gastric disease | 1/6 |
| General population | 17/302 |
| Genitourinary disease | 1/24 |
| Heart disease | 2/47 |
| Hepatitis | 2/31 |
| HIV | 3/39 |
| Injury | 1/60 |
| Kidney disease | 2/15 |
| Mental disorders | 3/65 |
| Multiple conditions | 3/130 |
| Musculoskeletal disease | 6/113 |
| Neurological disease | 3/78 |
| Respiratory disease | 3/32 |
| Rheumatic disease | 9/150 |
| Skin disease | 1/2 |
| Stroke | 3/71 |
| Thyroid disease | 1/12 |
PBM preference-based measures, EQ-5D-3L EuroQol-5 Dimensions, 3-Level Version, EQ-5D-5L EuroQol-5 Dimensions, 5-Level Version, EQ-VAS EuroQol-Visual Analog Scale, SF-6D Short Form-6 Dimensions, HUI Health Utilities Index, QWB Quality of Well-Being